Pacific Edge (Pacific Edge) Net Cash per Share : $0.03 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Pacific Edge Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Pacific Edge's Net Cash per Share for the quarter that ended in Mar. 2024 was $0.03.

The historical rank and industry rank for Pacific Edge's Net Cash per Share or its related term are showing as below:

PFGTF' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.46 Med: 12.2 Max: 50.5
Current: 1.46

During the past 13 years, the highest Price-to-Net-Cash Ratio of Pacific Edge was 50.50. The lowest was 1.46. And the median was 12.20.

PFGTF's Price-to-Net-Cash is ranked better than
82.67% of 75 companies
in the Medical Diagnostics & Research industry
Industry Median: 6.72 vs PFGTF: 1.46

Pacific Edge Net Cash per Share Historical Data

The historical data trend for Pacific Edge's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Edge Net Cash per Share Chart

Pacific Edge Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Cash per Share

Get a 7-Day Free Trial

0.01

0.02

0.09

0.06

0.03

Pacific Edge Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Net Cash per Share	Get a 7-Day Free Trial															0.09	0.06	0.06	0.04	0.03

Competitive Comparison of Pacific Edge's Net Cash per Share

For the Diagnostics & Research subindustry, Pacific Edge's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pacific Edge's Price-to-Net-Cash Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pacific Edge's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Pacific Edge's Price-to-Net-Cash falls into.

Pacific Edge Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Pacific Edge's Net Cash per Share for the fiscal year that ended in Mar. 2024 is calculated as

	Net Cash per Share (A: Mar. 2024 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(30.724	-	6.585	-	0)	/	811.271
=	0.03

Pacific Edge's Net Cash per Share for the quarter that ended in Mar. 2024 is calculated as

	Net Cash per Share (Q: Mar. 2024 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(30.724	-	6.585	-	0)	/	811.271
=	0.03

Pacific Edge (OTCPK:PFGTF) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

Pacific Edge Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Pacific Edge's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacific Edge (Pacific Edge) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pacific Edge Ltd (OTCPK:PFGTF) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

PEB:New Zealand PEB:Australia

Address

87 St David Street, P.O. Box 56, Dunedin, STL, NZL, 9016

Website

https://www.pacificedgedx.com

Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.